相似文献
1
In vivo magnetic resonance microimaging of individual amyloid plaques in Alzheimer's transgenic mice.
J Neurosci. 2005 Oct 26;25(43):10041-8. doi: 10.1523/JNEUROSCI.2588-05.2005.
2
Detection of amyloid plaques targeted by bifunctional USPIO in Alzheimer's disease transgenic mice using magnetic resonance microimaging.
PLoS One. 2013;8(2):e57097. doi: 10.1371/journal.pone.0057097. Epub 2013 Feb 27.
3
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Neurobiol Dis. 2002 Nov;11(2):315-29. doi: 10.1006/nbdi.2002.0550.
4
Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.
Magn Reson Med. 2005 Mar;53(3):607-13. doi: 10.1002/mrm.20385.
5
Gadolinium-staining reveals amyloid plaques in the brain of Alzheimer's transgenic mice.
Neurobiol Aging. 2012 Aug;33(8):1533-44. doi: 10.1016/j.neurobiolaging.2011.03.009. Epub 2011 Apr 30.
6
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.
Magn Reson Med. 2004 Dec;52(6):1263-71. doi: 10.1002/mrm.20266.
7
MR microimaging of amyloid plaques in Alzheimer's disease transgenic mice.
Eur J Nucl Med Mol Imaging. 2008 Mar;35 Suppl 1:S82-8. doi: 10.1007/s00259-007-0706-9.
8
Morphological characterization of Thioflavin-S-positive amyloid plaques in transgenic Alzheimer mice and effect of passive Abeta immunotherapy on their clearance.
Am J Pathol. 2004 Sep;165(3):987-95. doi: 10.1016/s0002-9440(10)63360-3.
9
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Magn Reson Med. 2003 Aug;50(2):293-302. doi: 10.1002/mrm.10529.
10
In vivo multi-parametric manganese-enhanced MRI for detecting amyloid plaques in rodent models of Alzheimer's disease.
Sci Rep. 2021 Jun 14;11(1):12419. doi: 10.1038/s41598-021-91899-5.
引用本文的文献
1
High iron in mouse olfactory ensheathing cells at the glia limitans in the olfactory bulb underlies MRI T * hypointensity.
Imaging Neurosci (Camb). 2024 Sep 30;2. doi: 10.1162/imag_a_00299. eCollection 2024.
2
Age-dependent microstructure alterations in 5xFAD mice by high-resolution diffusion tensor imaging.
Front Neurosci. 2022 Aug 17;16:964654. doi: 10.3389/fnins.2022.964654. eCollection 2022.
3
Multiscale optical and optoacoustic imaging of amyloid-β deposits in mice.
Nat Biomed Eng. 2022 Sep;6(9):1031-1044. doi: 10.1038/s41551-022-00906-1. Epub 2022 Jul 14.
4
Age-Dependent Changes in the Plasma and Brain Pharmacokinetics of Amyloid-β Peptides and Insulin.
J Alzheimers Dis. 2022;85(3):1031-1044. doi: 10.3233/JAD-215128.
5
Magnetic Resonance Imaging in Animal Models of Alzheimer's Disease Amyloidosis.
Int J Mol Sci. 2021 Nov 25;22(23):12768. doi: 10.3390/ijms222312768.
6
Associations of quantitative susceptibility mapping with Alzheimer's disease clinical and imaging markers.
Neuroimage. 2021 Jan 1;224:117433. doi: 10.1016/j.neuroimage.2020.117433. Epub 2020 Oct 6.
7
Magnetic Nanoparticles Applications for Amyloidosis Study and Detection: A Review.
Nanomaterials (Basel). 2018 Sep 18;8(9):740. doi: 10.3390/nano8090740.
8
Marked Age-Related Changes in Brain Iron Homeostasis in Amyloid Protein Precursor Knockout Mice.
Neurotherapeutics. 2018 Oct;15(4):1055-1062. doi: 10.1007/s13311-018-0656-x.
9
Unraveling the Burden of Iron in Neurodegeneration: Intersections with Amyloid Beta Peptide Pathology.
Oxid Med Cell Longev. 2018 Jan 31;2018:2850341. doi: 10.1155/2018/2850341. eCollection 2018.
10
Detection of β-Amyloid by Sialic Acid Coated Bovine Serum Albumin Magnetic Nanoparticles in a Mouse Model of Alzheimer's Disease.
Small. 2018 Jan;14(3). doi: 10.1002/smll.201701828. Epub 2017 Nov 14.
本文引用的文献
1
19F and 1H MRI detection of amyloid beta plaques in vivo.
Nat Neurosci. 2005 Apr;8(4):527-33. doi: 10.1038/nn1422. Epub 2005 Mar 13.
2
Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease.
Magn Reson Med. 2005 Mar;53(3):607-13. doi: 10.1002/mrm.20385.
3
In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent.
Magn Reson Med. 2004 Dec;52(6):1263-71. doi: 10.1002/mrm.20266.
4
Visualization of beta-amyloid plaques in a transgenic mouse model of Alzheimer's disease using MR microscopy without contrast reagents.
Magn Reson Med. 2004 Sep;52(3):538-44. doi: 10.1002/mrm.20196.
5
MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease.
Magn Reson Med. 2004 Apr;51(4):794-8. doi: 10.1002/mrm.20038.
6
Detection of amyloid plaques in mouse models of Alzheimer's disease by magnetic resonance imaging.
Magn Reson Med. 2004 Mar;51(3):452-7. doi: 10.1002/mrm.10730.
7
Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B.
Ann Neurol. 2004 Mar;55(3):306-19. doi: 10.1002/ana.20009.
8
Four-dimensional multiphoton imaging of brain entry, amyloid binding, and clearance of an amyloid-beta ligand in transgenic mice.
Proc Natl Acad Sci U S A. 2003 Oct 14;100(21):12462-7. doi: 10.1073/pnas.2034101100. Epub 2003 Sep 29.
9
Detection of Alzheimer's amyloid in transgenic mice using magnetic resonance microimaging.
Magn Reson Med. 2003 Aug;50(2):293-302. doi: 10.1002/mrm.10529.
10
Molecular targeting of Alzheimer's amyloid plaques for contrast-enhanced magnetic resonance imaging.
Neurobiol Dis. 2002 Nov;11(2):315-29. doi: 10.1006/nbdi.2002.0550.
Zotero 插件